11/14/2024
3:53 PM | Nantahala Capital Management, LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
09/23/2024
7:49 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
4:00 PM | FitzPatrick Margaret M (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:00 PM | Rotunno Mary L. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:00 PM | Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:00 PM | Curley Joanne (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:00 PM | GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/10/2024
4:00 PM | SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:49 PM | Vistagen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
3:53 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
6:00 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
07/16/2024
6:04 PM | Vistagen Therapeutics (Filer)
| Form DEFA14A | |
07/12/2024
3:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:34 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
5:06 PM | Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:07 PM | Adler Reid G. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:08 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:10 PM | Prince Joshua S. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:29 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
8:29 PM | Prince Joshua S. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
8:30 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
8:30 PM | Adler Reid G. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
8:31 PM | Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
6:18 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
8:52 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
4:29 PM | Vistagen Therapeutics (Filer)
| Form PRE 14A | |
03/06/2024
5:00 PM | SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Curley Joanne (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | FitzPatrick Margaret M (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Rotunno Mary L. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
11:15 PM | Vistagen Therapeutics (Filer)
| Form EFFECT | |
02/14/2024
5:18 PM | CITADEL ADVISORS LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:56 AM | Point72 Asset Management, L.P. (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
5:27 PM | StemPoint Capital LP (Filed by)
Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/03/2024
4:17 PM | Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Adler Reid G. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:09 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
